Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE

Showing 15 posts of 866 posts found.

NICE image

NICE starts new wave of quality standards

March 22, 2012
Sales and Marketing Commissioning Board, Future Forum, NHS, NICE

NICE has been given 123 new quality standards to work on, and includes for the first time new standards for …

News
NICE guidance app

NICE launches new guidance app

March 20, 2012
Medical Communications, Sales and Marketing Android, Apple, NICE, app, digital, guidance

NICE has launched a new app that allows mobile access to all of NICE’s recommendations and advice of the past …

News

NICE recommends Incivo for hepatitis C

March 16, 2012
Sales and Marketing Incivo, Janssen, NICE, Victrelis, telaprevir

NICE is recommending Janssen’s hepatitis C pill Incivo for funding on the NHS in England. The drug has bypassed the …

News
Gilenya picture

NICE U-turn sees Gilenya MS pill recommended

March 16, 2012
Sales and Marketing MS, NICE, UK, fingolimod, gilenya

NICE has changed its mind on Novartis’ multiple sclerosis pill Gilenya, and is now recommending the drug in a subgroup …

News
Pradaxa image

NICE recommends Pradaxa for stroke prevention

March 15, 2012
Sales and Marketing Boehringer Ingelheim, NICE, Pradaxa, atrial fibrillation

NICE has given a limited recommendation to Boehringer Ingelheim’s blood thinner Pradaxa. The watchdog said in final guidance that Pradaxa …

News
Zytiga image

Charity attacks Scottish decision on Zytiga

March 14, 2012
Sales and Marketing Janssen, NICE, PAS, Prostate Cancer Charity, Zytiga

Scotland’s medicines regulator has turned down Janssen’s prostate cancer pill Zytiga, leading to a backlash from charities. The Scottish Medicines …

News
Zelboraf image

Roche’s melanoma pill launched in UK

March 14, 2012
Sales and Marketing BMS, CDF, NICE, Roche, Yervoy, Zelboraf

Roche’s Zelboraf has been launched in the UK to treat the deadliest form of skin cancer.  Zelboraf (vemurafenib) is the …

News
Xarelto picture

NICE wants more information on Xarelto

March 13, 2012
Sales and Marketing Bayer, DVT, NICE, Xarelto

NICE is asking Bayer for more information about its blood thinner Xarelto in new guidance.  The watchdog is currently minded …

News
Victrelis picture

NICE recommends Victrelis in speedy review

March 9, 2012
Sales and Marketing Incivo, Janssen, Merck, NICE, Pegasus, Victrelis

NICE is recommending Merck’s hepatitis C pill Victrelis for funding in the NHS, in an expedited review.  In its final …

News
Zytiga image

Cancer Drugs Fund should not be used across the UK

March 7, 2012
Sales and Marketing CDF, Janssen, NICE, Zytiga, myloma, prostate

The Prostate Cancer Charity has said that extending England’s Cancer Drugs Fund to the UK will not solve the issue …

News
mark_baker_photograph2

NICE appoints two new directors

March 7, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mark Baker, NICE

The National Institute for Health and Clinical Excellence (NICE) has appointed two new directors. Professor Mark Baker will be the …

Appointment
Sir David Nicholson

Doctors don’t want rationing responsibility, finds survey

February 28, 2012
Sales and Marketing Commissioning Board, NHS, NHS reforms, NHSCB, NICE, rationing

 A survey of GPs in England has found that most do not want powers to ration care for NHS patients.The …

News

Witty hits out at ‘systematic delays’ to medicines

February 27, 2012
Sales and Marketing Europe, GSK, NICE, austerity

 GlaxoSmithKline’s chief executive says Europe’s drug budget cuts are undermining the industry and not addressing the biggest cost pressure in …

News
Zytiga image

Zytiga approved in Wales – for now

February 21, 2012
Sales and Marketing AWMSG, CDF, Janssen, NICE, Wales, Zytiga

Janssen’s cancer treatment Zytiga has been approved in Wales, in contrast to its rejection by NICE. The All Wales Medicines …

News
Tarceva image

NICE no for first line Tarceva

February 17, 2012
Sales and Marketing CDF, Cancer, NICE, Roche, Tarceva

NICE no for first line Tarceva Watchdog wants more information on Roche’s drug NICE is not recommending Roche’s lung cancer …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026